unknown
Stage
2022
Founded
1
Investors
About
Append develops a novel implant-free transcatheter system for left atrial appendage (LAA) elimination that uses a vacuum-driven inversion and ligation technique. The approach aims to achieve LAA closure without leaving an implanted device, reducing risks like device-related thrombosis and peri-device leak.
Explore Append's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.